Section 325.179b. Submission of HIV laboratory specimens.

Latest version.

All data is extracted from pdf, click here to view the pdf.

b. (1) A laboratory that receives any clinical specimen which yields results indicative of infection with human immunodeficiency virus (HIV) is responsible for ensuring that specimens are submitted to the department or to a laboratory designated by the department.   These specimens include any of the following:

(a)        Remnant    specimens    from      all      positive      western       blot       (WB)      or immunofluorescent antibody (IFA) confirmed tests.

(b)   Remnant specimens from viral detection or quantitation   tests upon request by the department within 3 months from specimen collection date, if available.

(c)    Remnant specimens from multiple reactive rapid enzyme immunoassay (EIA) tests that together constitute an HIV diagnosis.

History: 2009 AACS.

                    
                        var val = document.getElementById('citecontent').innerHTML;
                        art.dialog.defaults.title = window.location.href;
                        art.dialog.data('cite', val);
                        art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                        art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');